Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Sep 2011 - Clin. Cancer Res.; 17(17):1078-0432 [PMID:21771874]
[Lesterhuis WJ] [de Vries IJ] [Schreibelt G] [Lambeck AJ] [Aarntzen EH] [Jacobs JF] [Scharenborg NM] [van de Rakt MW] [de Boer AJ] [Croockewit S] [van Rossum MM] [Mus R] [Oyen WJ] [Boerman OC] [Lucas S] [Adema GJ] [Punt CJ] [Figdor CG]

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
Nov 2010 - Cancer Immunol. Immunother.:1432-0851 [PMID:21069321]
[Lesterhuis WJ] [Schreibelt G] [Scharenborg NM] [Brouwer HM] [Gerritsen MJ] [Croockewit S] [Coulie PG] [Torensma R] [Adema GJ] [Figdor CG] [de Vries IJ] [Punt CJ]